Clinical Trial

A Study Evaluating The Combination of Immunotherapy With Radiotherapy in Non-Small Cell Lung Cancer

Name: A Study Evaluating The Combination of Immunotherapy With Radiotherapy in Non-Small Cell Lung Cancer — clinical trial record (NCT07603856)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: REVIVE

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

Current clinical trials testing the combination of immunotherapy with radiotherapy.

Protocol Amendment History 1 change

critical Recruitment opened 2026-06-17

Trial Details

NCT Number	NCT07603856
Lead Sponsor	University of Chicago
Conditions	Non-Small Cell Lung Cancer, Metastatic Lung Cancer
Enrollment	39 participants
Start Date	2026-12-12
Primary Completion	2030-06-25 (estimated)
Study Completion	2030-06-25 (estimated)
Updated on ClinicalTrials.gov	2026-06-16